MedPath

Comparison between sugammadex and neostigmine for reversal of blockade in neurosurgery patients

Phase 3
Conditions
Health Condition 1: G969- Disorder of central nervous system, unspecifiedHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2024/05/068057
Lead Sponsor
Jawaharlal Nehru Medical CollegeDatta Meghe Institute of Higher Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a. Inclusion Criteria:

1. Consenting adults, undergoing elective intracranial tumor surgery under general anaesthesia with Vecuronium-induced neuromuscular blockade.

2.Adult patient above age of 18yrs -65yrs

3.No comorbidity

4.GCS –15/15

Exclusion Criteria

1.Patients with contraindications to Sugammadex or Neostigmine

2.Pre-existing neuromuscular disorders

3. Those requiring prolonged postoperative ventilation.

4.Malignant hyperthermia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath